Our current advocacy campaign: funding for type 1 diabetes research

Our current advocacy campaign:

We’re asking for $50 million for the next phase of the Type 1 Diabetes Clinical Research Network.

JDRF Australia’s
message: We want to create a world without type 1 diabetes (T1D). We won’t stop until we achieve our goal, and we know that research holds the key.

What we need to get there: To make this possible, we’re asking for $50 million for the next stage of the JDRF Australia Type 1 Diabetes Clinical Research Network (CRN), a Federally funded network that is the main supporter of T1D research in Australia.

The Albanese Government’s recent $6.5 million commitment in the May 2024 Budget is a welcome first step, ensuring research activity can continue for the coming year. But the full commitment is essential for the CRN to deliver to its full potential and change lives for the T1D community.


The breakthroughs made possible through the CRN

JDRF’s CRN has been in operation for a decade, significantly accelerating progress. Here are just a few examples of what the CRN has made possible.

JDRF’s amazing advocates have been a key driver of these breakthroughs, helping to achieve Government investment in the CRN in 2010, 2014, 2019, and 2024, making sure that leading researchers could continue their work.

We’re now on the brink of many more life-changing breakthroughs in treatment and technology, yet for these to be realised in full, we must secure an additional $50 million in funding for the CRN.


What’s next?

With further funding, the next phase of the CRN will be able to accelerate three areas of research that we know will drive us closer to a world without T1D and deliver real, impactful change for the community.


We want to build on the progress of existing prevention research, such as expanding our understanding of which environmental exposures can trigger the onset of T1D, rolling out a general population screening program to ensure every Australian child at risk of developing T1D is detected before symptoms begin, and developing therapies that can stop T1D in its tracks.  


We will invest in precision medicine research to create a future where we can provide the right treatment to the right person at the right time. This would mean moving away from a ‘one size fits all’ approach, so everyone with T1D can have access to the best health care. 


We will not stop until we find a cure, and that means pushing new therapies through clinical trials, looking at exciting research areas like stem cells, and providing career support to the best and brightest T1D researchers to keep them in the field.  


Learn more about research funded through the CRN.

Learn more about becoming an advocate.


Type 1 diabetes can only be solved through research.

Mike Wilsom OAM, JDRF Australia CEO